Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer

Author: Hombach Andreas A   Abken Hinrich  

Publisher: Future Medicine

ISSN: 1750-743X

Source: Immunotherapy, Vol.5, Iss.7, 2013-07, pp. : 677-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract